Evidence map›Paper›PMID 36588553›Full record

ArticleFrontiers in cardiovascular medicine2022

Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry.

Francesca Girolami, Valentina Spinelli, Niccolò Maurizi, Martina Focardi, Gabriella Nesi, Vincenza Maio, Rossella Grifoni, Giuseppe Albora, Bruno Bertaccini, Mattia Targetti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Francesca GirolamiCardiology Unit, Meyer Children's University Hospital, Florence, Italy.
Valentina SpinelliDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Niccolò MauriziCareggi University Hospital, Florence, Italy.
Martina FocardiCareggi University Hospital, Florence, Italy.
Gabriella NesiCareggi University Hospital, Florence, Italy.
Vincenza MaioCareggi University Hospital, Florence, Italy.
Rossella GrifoniCareggi University Hospital, Florence, Italy.
Giuseppe AlboraCareggi University Hospital, Florence, Italy.
Bruno BertacciniDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.
Mattia TargettiCareggi University Hospital, Florence, Italy.
Raffaele CoppiniDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Silvia FavilliCardiology Unit, Meyer Children's University Hospital, Florence, Italy.
Iacopo OlivottoCardiology Unit, Meyer Children's University Hospital, Florence, Italy.
Elisabetta CerbaiDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · ITMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sudden cardiac arrest (SCA) in young people represents a dramatic event, often leading to severe neurologic outcomes or sudden cardiac death (SCD), and is frequently caused by genetic heart diseases. In this study, we report the results of the Tuscany registry of sudden cardiac death (ToRSADE) registry, aimed at monitoring the incidence and investigating the genetic basis of SCA and SCD occurring in subjects < 50 years of age in Tuscany, Italy. Methods and results: Creation of the ToRSADE registry allowed implementation of a repository for clinical, molecular and genetic data. For 22 patients, in whom a genetic substrate was documented or suspected, blood samples could be analyzed; 14 were collected at autopsy and 8 from resuscitated patients after SCA. Next generation sequencing (NGS) analysis revealed likely pathogenetic (LP) variants associated with cardiomyopathy (CM) or channelopathy in four patients (19%), while 17 (81%) carried variants of uncertain significance in relevant genes (VUS). In only one patient NGS confirmed the diagnosis obtained during autopsy: the p.(Asn480Lysfs*20) PKP2 mutation in a patient with arrhythmogenic cardiomyopathy (AC). Conclusion: Systematic genetic screening allowed identification of LP variants in 19% of consecutive patients with SCA/SCD, including subjects carrying variants associated with hypertrophic cardiomyopathy (HCM) or AC who had SCA/SCD in the absence of structural cardiomyopathy phenotype. Genetic analysis combined with clinical information in survived patients and post-mortem evaluation represent an essential multi-disciplinary approach to manage juvenile SCD and SCA, key to providing appropriate medical and genetic assistance to families, and advancing knowledge on the basis of arrhythmogenic mechanisms in inherited cardiomyopathies and channelopathies.

Indexed as

arrhythmiageneticsjuvenile sudden cardiac deathmolecular autopsynext generation sequencingToRSADE registry

Identifiers

PMID36588553
PMCPMC9795053
OpenAlexW4311377824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.